Form 8-K - Current report:
SEC Accession No. 0000950170-25-003873
Filing Date
2025-01-10
Accepted
2025-01-10 09:26:43
Documents
11
Period of Report
2025-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K achv-20250106.htm   iXBRL 8-K 48927
  Complete submission text file 0000950170-25-003873.txt   203927

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT achv-20250106.xsd EX-101.SCH 51388
13 EXTRACTED XBRL INSTANCE DOCUMENT achv-20250106_htm.xml XML 6342
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 25520820
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)